Chihiro Suzuki

Back to Authors

DataCiteX Author Profile

Research profile with citations, yearly trend, article performance and author insights

Princess Margaret Cancer Centre, Canada

ORCID: -

DataCiteX Author Profile

Chihiro Suzuki

Profile Status Approved & Active

Last Synced 04 Aug 2026, 01:55 PM

Visit Website

Author Impact Score

Custom 3-year author impact calculator based on citations and indexed documents.

23.00

Author impact score

138 Citations 2024 - 2026

6 Documents 2024 - 2026

Total Citations

212

Scholar + author-added

H-Index

8

research impact

I10-Index

7

quality score

Articles Found

27

merged research works

Top Performing Year

2025

66 citations

Tier

T2

CiteScore rank tier

Author CiteScore

23.00

Declining trend

Avg Citations / Year

23.44

yearly average

Citations / Article

7.85

impact efficiency

Citation Trend

40

Declining trend

Most Cited Article

Vonoprazan as a long-term maintenance t...

64 citations

Smart Insight Box

Auto Summary

Top citation year was 2025 with 66 citations. Average citations per year stand at 23.44. Each indexed article contributes around 7.85 citations on average. Latest Author Impact Score for 2026 is 23, indicating a declining trend. Current H-index is 8 and I10-index is 7. Most cited article currently has 64 citations. Recent yearly citation pattern indicates a declining trend.

Author Impact Score Trend

7 Years

Most Cited

64 Citations

Year: 2025

Vonoprazan as a long-term maintenance treatment for erosive esophagitis: VISION, a 5-year, randomized, open-label study

N Uemura, Y Kinoshita, K Haruma, R Kushima, T Yao, J Akiyama, ...

Clinical Gastroenterology and Hepatology 23 (5), 748-757. e5, 2025

Yearly Citations

Author year-wise citation data

Year	Citations
2026	40
2025	66
2024	32
2023	27
2022	14
2021	10
2020	12
2019	6
2018	4

Yearly Citations Chart

Author citation trend

9 Years

Year-wise Citation Share

Citation percentage by year

Top Research Articles

Showing 20 articles per page

27 Articles Page 1 of 2

#	Article Details	Year
1	Vonoprazan as a long-term maintenance treatment for erosive esophagitis: VISION, a 5-year, randomized, open-label study Google Scholar 👨‍🔬 N Uemura, Y Kinoshita, K Haruma, R Kushima, T Yao, J Akiyama, ... 📚 Clinical Gastroenterology and Hepatology 23 (5), 748-757. e5, 2025	2025
2	Variations in the viral genome and biological properties of bovine leukemia virus wild-type strains Google Scholar 👨‍🔬 H Murakami, J Uchiyama, C Suzuki, S Nikaido, K Shibuya, R Sato, ... 📚 Virus research 253, 103-111, 2018	2018
3	Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma Google Scholar 👨‍🔬 LX Ma, K Taylor, O Espin‐Garcia, R Anconina, C Suzuki, MJ Allen, ... 📚 Cancer Medicine 10 (1), 199-207, 2021	2021
4	Influence of sarcopenia, clinical data, and 2-[18F] FDG PET/CT in outcome prediction of patients with early-stage adenocarcinoma esophageal cancer Google Scholar 👨‍🔬 R Anconina, C Ortega, U Metser, ZA Liu, C Suzuki, M McInnis, GE Darling, ... 📚 European Journal of Nuclear Medicine and Molecular Imaging 49 (3), 1012-1020, 2022	2022
5	Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastric and esophageal cancers Google Scholar 👨‍🔬 LX Ma, O Espin-Garcia, CH Lim, DM Jiang, HW Sim, A Natori, BA Chan, ... 📚 Journal of gastrointestinal oncology 11 (2), 356, 2020	2020
6	Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma Google Scholar 👨‍🔬 DM Jiang, C Suzuki, O Espin‐Garcia, CH Lim, LX Ma, P Sun, HW Sim, ... 📚 Cancer medicine 9 (9), 3023-3032, 2020	2020
7	Long-term safety and effectiveness of vonoprazan for prevention of gastric and duodenal ulcer recurrence in patients on nonsteroidal anti-inflammatory drugs in Japan: a 12 … Google Scholar 👨‍🔬 T Kawai, C Suzuki, Y Honda, JL Fernandez 📚 Expert Opinion on Drug Safety 22 (5), 425-431, 2023	2023
8	Gastric cancer risk after Helicobacter pylori eradication in gastritis and peptic ulcer: a retrospective cohort study in Japan Google Scholar 👨‍🔬 K Sugano, C Suzuki, M Ota, R Iwakiri 📚 BMC gastroenterology 25 (1), 463, 2025	2025
9	Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan Google Scholar 👨‍🔬 K Tokunaga, C Suzuki, M Hasegawa, I Fujimori 📚 ClinicoEconomics and Outcomes Research, 241-250, 2021	2021
10	Combination of clinical, radiomic, and “delta” radiomic features in survival prediction of metastatic gastroesophageal adenocarcinoma Google Scholar 👨‍🔬 S Krishna, A Sertic, ZA Liu, Z Liu, GE Darling, J Yeung, R Wong, EX Chen, ... 📚 Frontiers in oncology 13, 892393, 2023	2023
11	Gastric and gastroesophageal adenocarcinoma survival outcomes relative to completion of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): a single … Google Scholar 👨‍🔬 E Panov 📚 Journal of Clinical Oncology, 2021	2021
12	Long-term safety and effectiveness of vonoprazan as maintenance therapy for reflux esophagitis in Japan: a 12-month post-marketing surveillance study Google Scholar 👨‍🔬 N Manabe, M Matsuo, C Suzuki 📚 Expert Opinion on Drug Safety, 1-10, 2026	2026
13	Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10%(FSCIG 10%) as a Maintenance Therapy for Japanese Patients with CIDP and MMN: A Phase-3 Open-Label Clinical Study Google Scholar 👨‍🔬 S Kuwabara, K Shibuya, Y Tomizawa, H Ogata, S Shima, A Kuga, ... 📚 JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 31, 2026	2026
14	Pharmacokinetics, safety and tolerability, and efficacy of hyaluronidase-facilitated subcutaneous immunoglobulin 10% (HyQvia®) in Japanese patients with primary … Google Scholar 👨‍🔬 H Kanegane, M Ishimura, E Suganuma, T Imagawa, T Hoshina, T Kawai, ... 📚 Immunological Medicine, 1-13, 2026	2026
15	A Phase 1/2, Open-Label, Single-Dose, Multicenter Study to Evaluate the Pharmacokinetics and Safety of Human Plasma-Derived Protein C Concentrate in Japanese Patients with … Google Scholar 👨‍🔬 K Koh, K Nogami, H Kakuda, Y Okimoto, M Hino, Y Tanigawara, Z Li, ... 📚 Journal of Blood Medicine, 535025, 2026	2026
16	Survival prediction using radiomic signatures in metastatic gastric and esophageal adenocarcinoma (GEA). Google Scholar 👨‍🔬 MJ Allen, A Sertic, Z Liu, Z Liu, C Suzuki, ED Panov, LX Ma, Y Bach, ... 📚 Journal of Clinical Oncology 40 (4_suppl), 357-357, 2022	2022
17	Impact of age on outcomes and symptoms in patients with advanced gastroesophageal cancer (GEC). Google Scholar 👨‍🔬 F Almugbel, L Al-Showbaki, H Alqaisi, C Suzuki, O Espin-Garcia, ... 📚 Journal of Clinical Oncology 39 (3_suppl), 193-193, 2021	2021
18	Predictors of survival after metastasectomy of oligometastatic recurrence following gastroesophageal cancer treatment. Google Scholar 👨‍🔬 M MacKenzie, LX Ma, O Epsin-Garcia, C Suzuki, Y Bach, MJ Allen, ... 📚 Journal of Clinical Oncology 39 (15_suppl), e16060-e16060, 2021	2021
19	Combining Sarcopenia and [18F] FDGPET/CT Derived Metabolic Parameters in Patients with Adenocarcinoma Esophageal Cancer Might Improve Outcome Prediction Google Scholar 👨‍🔬 R Anconina, C Ortega, U Metser, ZA Liu, C Suzuki, M McInnis, GE Darling, ...	2021
20	1406P Survival outcomes in older adults with metastatic gastric and esophageal carcinoma receiving palliative chemotherapy Google Scholar 👨‍🔬 MJ Allen, O Espin-Garcia, C Suzuki, E Panov, L Ma, B Yvonne, R Jang, ... 📚 Annals of Oncology 32, S1058-S1059, 2021	2021
21	Clinicopathological features and treatment outcomes of young patients with gastric and esophageal cancers. Google Scholar 👨‍🔬 LA Beck, LX Ma, O Espin-Garcia, C Suzuki, DM Jiang, G Liu, EX Chen, ... 📚 Journal of Clinical Oncology 38 (4_suppl), 325-325, 2020	2020
22	Patterns of disease, treatment, and outcomes of esophageal cancer arising within a previous radiation treatment field. Google Scholar 👨‍🔬 LX Ma, P Sun, O Espin-Garcia, C Suzuki, DM Jiang, CH Lim, K Taylor, ... 📚 Journal of Clinical Oncology 38 (4_suppl), 328-328, 2020	2020
23	Outcomes relative to paclitaxel dose-intensity when administered with ramucirumab in gastric and gastroesophageal junction (GEJ) adenocarcinoma. Google Scholar 👨‍🔬 MJ Allen, C Suzuki, O Espin-Garcia, LX Ma, M Honório, I Lyra-Gonzalez, ... 📚 Journal of Clinical Oncology 38 (15_suppl), e16539-e16539, 2020	2020
24	1460P Impact of sites of metastatic dissemination on survival in advanced gastroesophageal adenocarcinoma Google Scholar 👨‍🔬 X Wang, O Espin-Garcia, C Suzuki, Y Bach, D Jiang, LX Ma, MJ Allen, ... 📚 Annals of Oncology 31, S915, 2020	2020
25	1464P Asian-ethnicity related differences among patients with metastatic gastroesophageal junction (GEJ) and gastric adenocarcinoma Google Scholar 👨‍🔬 MX Honório, C Suzuki, O Espin-Garcia, MJ Allen, L Ma, FA Almugbel, ... 📚 Annals of Oncology 31, S917, 2020	2020
26	Impact of sites of metastatic dissemination on survival in advanced gastroesophageal adenocarcinoma Google Scholar 👨‍🔬 X Wang, O Espin-Garcia, C Suzuki, Y Bach, D Jiang, LX Ma, MJ Allen, ... 📚 ANNALS OF ONCOLOGY 31, S915-S915, 2020	2020
27	Impact of adjuvant therapy in patients with a microscopically positive margin after resection for gastroesophageal cancer. Google Scholar 👨‍🔬 LX Ma, O Espin-Garcia, CH Lim, P Sun, DM Jiang, HW Sim, A Natori, ... 📚 Journal of Clinical Oncology 37 (4_suppl), 164-164, 2019	2019

Showing 1 to 20 of 27 articles

Chihiro Suzuki

DataCiteX Author Profile

Author Impact Score

212

8

7

27

2025

T2

23.00

23.44

7.85

40

Vonoprazan as a long-term maintenance t...

Smart Insight Box

Author Impact Score Trend

Most Cited

Yearly Citations

Yearly Citations Chart

Year-wise Citation Share

Top Research Articles

Explore the Global Research Landscape